Kriya Therapeutics: Gene Therapy. Redefined.
Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have …
Pipeline - Kriya Therapeutics
Kriya is developing a portfolio of one-time gene therapies in ophthalmology, metabolic disease and neurology.
Our Team: Leaders in Gene Therapy - Kriya Therapeutics
Kriya’s team of gene therapy pioneers and biopharma veterans is building a pipeline to address common diseases.
Careers: Future of Gene Therapy - Kriya Therapeutics
Careers Kriya is Changing the Future of Gene Therapy We have an ambitious set of goals, but our confidence – and our inspiration – stems from our people. From California to North Carolina, our …
Kriya Announces $320 Million Series D Financing to Advance Pipeline …
Sep 10, 2025 · Kriya’s pipeline includes focally delivered gene therapies for chronic diseases, including Geographic Atrophy, Thyroid Eye Disease, Type 1 Diabetes, Metabolic Associated Steatohepatitis …
Kriya Announces Thirteen Presentations at the American Society of …
Apr 29, 2025 · Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world. With operations in Research Triangle Park, …
Metabolic Disease: Gene Therapy for Diabetes and NASH - Kriya …
Kriya is developing KRIYA 839, a potential one-time gene therapy for type 1 diabetes expressing insulin and glucokinase, designed to be delivered intramuscularly with the objective of driving durable …
Research & Development - Kriya Therapeutics
Kriya is pioneering a new paradigm for gene therapy R&D that empowers our team of gene therapy veterans to overcome these challenges and operate at the scale needed to address chronic diseases.
Kriya Presents Data at the 2025 Association for Research in Vision and ...
Kriya is developing KRIYA-825, a potential one-time gene therapy for Geographic Atrophy (GA) that expresses a fusion protein designed to inhibit the activity of complement C3 and C5, with the …
Newsroom: Gene Therapy Pipeline News - Kriya Therapeutics
Sep 12, 2024 · Kriya shares the latest news on our pipeline of life-changing gene therapies to address common diseases.